FDA FY 2024 Budget Includes 10% Funding Boost, But No Movement On Diagnostics

The FDA requested a 10% increase in budget authority for FY 2024, but diagnostic reform was left out of the proposal. 

• Source: Shutterstock

The Food and Drug Administration’s $7.2bn FY 2024 budget is an increase of $372m (10%) in budget authority from last year but does not include any indication the agency is looking for funds for the much-anticipated diagnostics reform.

This was a surprise to some because the FDA often uses budget proposals to highlight its priorities, and regulators in...

More from Regulation

More from Policy & Regulation